Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2

Por Verma, Sharad K., Tian, Xinrong, LaFrance, Louis V., Duquenne, Céline, Suarez, Dominic P., Newlander, Kenneth A., Romeril, Stuart P., Burgess, Joelle L., Grant, Seth W., Brackley, James A., Graves, Alan P., Scherzer, Daryl A., Shu, Art, Thompson, Christine, Ott, Heidi M., Aller, Glenn S. Van, Machutta, Carl A., Diaz, Elsie, Jiang, Yong, Johnson, Neil W., Knight, Steven D., Kruger, Ryan G., McCabe, Michael T., Dhanak, Dashyant, Tummino, Peter J., Creasy, Caretha L., Miller, William H.
Publicado em 2012

Design of potent and selective human cathepsin K inhibitors that span the active site

Por Thompson, Scott K., Halbert, Stacie M., Bossard, Mary J., Tomaszek, Thaddeus A., Levy, Mark A., Zhao, Baoguang, Smith, Ward W., Abdel-Meguid, Sherin S., Janson, Cheryl A., D’Alessio, Karla J., McQueney, Michael S., Amegadzie, Bernard Y., Hanning, Charles R., DesJarlais, Renee L., Briand, Jacques, Sarkar, Susanta K., Huddleston, Michael J., Ijames, Carl F., Carr, Steven A., Garnes, Keith T., Shu, Art, Heys, J. Richard, Bradbeer, Jeremy, Zembryki, Denise, Lee-Rykaczewski, Liz, James, Ian E., Lark, Michael W., Drake, Fred H., Gowen, Maxine, Gleason, John G., Veber, Daniel F.
Publicado em 1997